SGMO - Sangamo Therapeutics Inc. (SGMO) CEO Sandy Macrae on Q2 2021 Results - Earnings Call Transcript

Sangamo Therapeutics, Inc. (SGMO) Q2 2022 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Aron Feingold - Head of Corporate Communications & Investor Relations Officer Sandy Macrae - President & Chief Executive Officer Prathyusha Duraibabu - Chief Financial Officer Rob Schott - Senior Vice President & Head of Development Jason Fontenot - Senior Vice President & Chief Scientific Officer Mark McClung - Executive Vice President & Chief Business Officer Conference Call Participants Yanan Zhu - Wells Fargo Securities, LLC Aspen Mori - Bank of America Merrill Lynch Gena Wang - Barclays Ritu Baral - Cowen & Company Kellie Briza - Stifel Presentation Operator Good day, everyone and thank you for standing by and welcome to the Sangamo Second Quarter Of 2021 Teleconference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] I would now

For further details see:

Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q2 2021 Results - Earnings Call Transcript